Medicare Enrolled
Dr. Payman Khorrami, MD
Gastroenterology · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khorrami from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khorrami?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khorrami
Dr. Payman Khorrami is a gastroenterology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khorrami performed 4,157 Medicare services across 1,813 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khorrami received a total of $10,647 from 47 pharmaceutical and/or device companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khorrami is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$10,647 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,157
Medicare services
Top 3% in CA for gastroenterology
1,813
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~219 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,907 | $68 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
574 | $111 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
466 | $102 | $275 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
264 | $149 | $550 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
187 | $71 | $2,000 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
171 | $156 | $400 |
| New patient office visit, complex (60-74 min) | 159 | $186 | $550 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
151 | $135 | $2,300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $78 | $200 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
40 | $198 | $2,400 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
29 | $157 | $1,800 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
28 | $144 | $325 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
21 | $14 | $2,200 |
| Small bowel biopsy via endoscope A procedure to collect tissue samples from the small intestine using an endoscope. The sample is taken from the small bowel, excluding the ileum. |
20 | $80 | $900 |
| Endoscopic insertion of stomach tube A flexible endoscope is used to guide the placement of a tube into the stomach. |
18 | $164 | $1,100 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $111 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,647
Total received (2018-2024)
Avg $1,521/year across 7 years
Top 18% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
437
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,622 (99.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,865
2023
$1,819
2022
$1,884
2021
$969
2020
$222
2019
$1,497
2018
$1,390
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$735
Janssen Biotech, Inc.
$718
QOL Medical, LLC
$283
Phathom Pharmaceuticals, Inc.
$156
AIMMUNE THERAPEUTICS, INC.
$120
Ardelyx, Inc.
$118
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$114
Madrigal Pharmaceuticals
$106
Lilly USA, LLC
$96
Novo Nordisk Inc
$81
Amgen Inc.
$70
Celltrion USA Inc.
$60
Novartis Pharmaceuticals Corporation
$58
Celgene Corporation
$52
IRONWOOD PHARMACEUTICALS, INC
$50
Abbott Laboratories
$47
Top 3 companies account for 60.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,035
Janssen Biotech, Inc.
$1,741
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,085
AbbVie, Inc.
$544
PFIZER INC.
$535
QOL Medical, LLC
$491
Ardelyx, Inc.
$395
AbbVie Inc.
$377
Celgene Corporation
$343
Ferring Pharmaceuticals Inc.
$276
Janssen Scientific Affairs, LLC
$234
Ironwood Pharmaceuticals, Inc
$175
Amgen Inc.
$164
Takeda Pharmaceuticals U.S.A., Inc.
$163
Phathom Pharmaceuticals, Inc.
$156
Allergan Inc.
$155
Romark Laboratories, LC
$122
AIMMUNE THERAPEUTICS, INC.
$120
Nestle HealthCare Nutrition Inc.
$114
Madrigal Pharmaceuticals
$106
Boston Scientific Corporation
$105
Novo Nordisk Inc
$103
E.R. Squibb & Sons, L.L.C.
$102
Lilly USA, LLC
$96
NESTLE HEALTHCARE NUTRITION INC.
$83
Synergy Pharmaceuticals Inc
$74
Daiichi Sankyo Inc.
$67
Celltrion USA Inc.
$60
Novartis Pharmaceuticals Corporation
$58
Merck Sharp & Dohme Corporation
$52
IRONWOOD PHARMACEUTICALS, INC
$50
Abbott Laboratories
$47
Concordia Pharmaceuticals Inc.
$46
RedHill Biopharma Inc.
$42
Prometheus Laboratories Inc.
$41
Braintree Laboratories, Inc.
$37
Gilead Sciences, Inc.
$32
AstraZeneca Pharmaceuticals LP
$29
Organon LLC
$26
Intercept Pharmaceuticals, Inc.
$25
Evoke Pharma, Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$23
Allergan, Inc.
$21
Alexion Pharmaceuticals, Inc.
$20
Exact Sciences Corporation
$20
Shire North American Group Inc
$19
Shionogi Inc
$14
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
APRISO · Aemcolo · Alinia Tablets 500mg 30 count bottle · CIMZIA · CLENPIQ · COMIRNATY · CREON · Cologuard Collection Kit · Creon · DIFICID · Donnatal · ENTYVIO · EVENITY · Entyvio · FREESTYLE LIBRE 3 · GATTEX · GENERAL PAIN MANAGEMENT · GIMOTI · HADLIMA · HUMIRA · Humira · IBSRELA · INJECTAFER · KAPSPARGO · Kanuma · LEQVIO · LINZESS · LUCEMYRA · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · MOVANTIK · Motegrity · NOCDURNA · OCALIVA · OMVOH · Otezla · Ozempic · Prolia · REBYOTA · RELISTOR · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · Saxenda · Sucraid · Symproic · TEPEZZA · TREMFYA · TRULANCE · Talicia · Trulance · UBRELVY · UCERIS TABLETS · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · Wegovy · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPATIER · ZEPBOUND · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
454
Per 100K population
4.6
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - WEST LA
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khorrami is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khorrami experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Khorrami performed 1,907 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khorrami receive payments from pharmaceutical companies?
Yes. Dr. Khorrami received a total of $10,647 from 47 companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khorrami's costs compare to other gastroenterologists in Los Angeles?
Dr. Khorrami's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khorrami) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Los Angeles
Browse gastroenterologists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology